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Mature Enzymatic Collagen Cross-Links,
Hydroxylysylpyridinoline and Lysylpyridinoline,
in the Aging Human Vitreous
Theodorus L. Ponsioen,1,2 Marielle van Deemter,1,2 Rudolf A. Bank,3,4
Johanna M. Snabel,3,4 Gerrit S. Zijlstra,5 Roelofje J. van der Worp,1,2
Johanna M. M. Hooymans,1,2 and Leonoor I. Los1,2
PURPOSE. The vitreous body of the human eye undergoes pro-
gressive morphologic changes with aging. Since the enzymatic
collagen cross-links hydroxylysylpyridinoline (HP) and ly-
sylpyridinoline (LP) are known to be important for the integrity
of the collagen matrix, the presence in the vitreous on aging
was studied.
METHODS. Vitreous bodies (VBs; n 143) from 119 donors (age
4–80 years; mean  SD, 54.3  17.0 years) were carefully
dissected. After weighing and freeze-drying, all samples were
analyzed by high performance liquid chromatography. Left and
right eyes of 24 donors were compared and, for age-related
phenomena, 119 single eyes were used.
RESULTS. Within one donor, no significant differences were
found between left and right eyes. On aging, VB wet weight
(4.42  0.84 g) accumulates until 35 years and decreases
thereafter. Collagen content (0.30  0.14 mg), HP per triple
helix (TH; 0.55  0.18), and (HP plus LP)/TH (0.61  0.19)
increase until 50 years followed by a decrease, whereas LP/TH
(0.057  0.018) accumulates until 50 years and remains con-
stant thereafter. The ratio between HP and LP (range, 0.42–
31.0; median, 10.0) is constant over time.
CONCLUSIONS. The accumulation of enzymatic collagen cross-
links until 50 years is consistent with collagen maturation and
possible collagen synthesis in the human vitreous body. The
decline of collagen cross-links after 50 years is consistent with
collagen breakdown. (Invest Ophthalmol Vis Sci. 2009;50:
1041–1046) DOI:10.1167/iovs.08-1714
The vitreous body of the human eye is the transparent andhighly hydrated (98%–99% water) extracellular matrix
(ECM) located behind the lens and surrounded by and attached
to the retina. Its structure is maintained by heterotypic colla-
gen fibrils, which contain collagen types II, V/XI, and IX, with
type II predominating.1 Types II, V, and XI collagen belong to
the family of the fibril-forming collagens that assemble into
fibrils and can form stable cross-links; type IX collagen belongs
to the family of the fibril-associated collagens that is covalently
linked to the surface of collagen fibrils.2 Collagen fibrils in their
turn can aggregate into collagen fibers. Enzymatic collagen
cross-links are essential for the physical and mechanical prop-
erties of the collagen fibers.3
The formation of enzymatic collagen cross-links is preceded
by collagen synthesis (Fig. 1). Synthesis of fibril-forming colla-
gens (e.g., type II) starts with the transcription of the gene
within the cell nucleus followed by its translation. After trans-
lation, procollagens are formed; these undergo multiple post-
translational modifications (e.g., the hydroxylation of specific
proline and lysine residues and the glycosylation of hydroxyl-
ysine residues) before their secretion into the ECM. The hy-
droxylation of lysine residues within the triple helix, as well as
the C- and N-telopeptides, is catalyzed by lysyl hydroxylases.4
In the ECM, the C- and N-terminal propeptides are removed by
proteinases, enabling the molecules to aggregate into fibrils.5–8
Subsequently, collagen fibrils are stabilized by the formation of
enzymatic intermolecular and/or intramolecular cross-links.
The formation of cross-links starts with the oxidative deamina-
tion of the -amino group of specific lysine and hydroxylysine
residues within the C- and N-terminal telopeptides, leading to
the formation of reactive aldehydes. The conversion of lysine
and hydroxylysine into the respective aldehydes allysine and
hydroxyallysine is catalyzed by the enzyme lysyl oxidase. The
reactive aldehyde condensates either with hydroxylysine or
lysine within an adjacent collagen molecule to form the stable
intermolecular cross-links hydroxylysylpyridinoline (HP) and
lysylpyridinoline (LP).4,7,9,10
With aging, the human vitreous undergoes a progressive
increase in liquefied spaces (synchisis11–14) as well as an in-
crease in optically dense structures (syneresis).15,16 The first
evidence of liquefaction has been observed at age 4 years.13
Synchisis and syneresis progress slowly, and these processes
can be followed by a posterior vitreous detachment (PVD),
which is a separation between the vitreous cortex and the
retina.11,12,14,17 Postmortem studies reported that 45% of per-
sons aged 60 to 69 years had at least 50% liquefaction,14 that
PVD is first seen in the sixth decade of life, and that 50% to 60%
of persons aged 80 to 90 years had a PVD.17 Posterior vitreous
detachment in itself is not a serious condition, although it may
lead to local interference with the passage of light and cause
symptoms referred to as ‘mouches volantes’ or floaters. How-
ever, it may induce more serious pathology, such as retinal
tears, retinal detachment, and intravitreal hemorrhage.18 The
pathophysiologic mechanisms underlying synchisis and syne-
resis have not yet been clarified. Currently, two possible mech-
anisms are discussed in the literature. Generally, synchisis is
supposed to start with changes in the noncollagenous compo-
nents of the matrix and to result in an aggregation of collagen
From the 1University Medical Center Groningen and the Depart-
ments of 2Ophthalmology and 5Pharmaceutical Technology and Bio-
pharmacy, University of Groningen, Groningen, The Netherlands;
3TNO Quality of Life, Division BioSciences, Leiden, The Netherlands;
and the 4Academic Center of Dentistry Amsterdam, Vrije Universiteit,
Department of Oral Biology, Amsterdam, The Netherlands.
Supported by Rotterdamse Vereniging Blindenbelangen, Rotter-
dam, The Netherlands; Stichting OOG (Ondersteuning Oogheelkunde
’s Gravenhage), The Hague, The Netherlands; and Stichting Blinden-
hulp, The Hague, The Netherlands.
Submitted for publication January 9, 2008; revised May 15 and July
8, 2008; accepted January 20, 2009.
Disclosure: T.L. Ponsioen, None; M. van Deemter, None; R.A.
Bank, None; J.M. Snabel, None; G.S. Zijlstra, None; R.J. van der
Worp, None; J.M.M. Hooymans, None; L.I. Los, None
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked “advertise-
ment” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Theodorus L. Ponsioen, University Medical
Center Groningen and University of Groningen, P.O. Box 30.001, 9700
RB Groningen, The Netherlands; t.l.ponsioen@ohk.umcg.nl.
Investigative Ophthalmology & Visual Science, March 2009, Vol. 50, No. 3
Copyright © Association for Research in Vision and Ophthalmology 1041
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/932958/ on 05/03/2018
fibrils.1,16,19–22 Following this theory, synchisis and syneresis
are the structural manifestations of a destabilization of the
vitreous matrix.13,16,19 More recent studies find evidence of an
alternative hypothesis, in which a breakdown of the vitreous
matrix leading to synchisis23 would coincide with the synthesis
of vitreous collagen,24–29 leading to an increase in optically
dense structures on aging (syneresis). In this theory, synchisis
and syneresis can occur at different locations within the matrix
and by different physiologic and pathophysiologic mecha-
nisms.
In this study, we measured the contents of both HP and LP
cross-links in whole human vitreous with aging, since the role
of enzymatic collagen cross-links has not specifically been
studied in the aging process of the vitreous. We show the
presence of HP and LP cross-links, which appear to reach their
maximum before the general onset of liquefaction.14
METHODS
Vitreous Preparation
Human eyes (n  143) from 119 donors (80 men and 39 women) with
ages varying from 4 to 80 years (mean, 54.3  17.0 years) and with no
known ophthalmic disorders were obtained from the Cornea Bank
(Amsterdam, The Netherlands). Twelve donors (18 eyes) had diabetes
mellitus and only one donor (age 75) had a complete PVD, defined as
complete posterior detachment of the vitreous cortex from the retina
until the vitreous base. Vitreous bodies (VBs) were prepared under a
dissection microscope within 1 to 14 days postmortem (mean, 5.6 
2.6 days) according to a standard protocol previously described by
Worst.30 In short, eyes were placed in an eye holder filled with sodium
chloride 0.9% and remained below the surface. Sclera, choroid, lens,
and iris were removed. After blunt cleaving, almost all retina and ciliary
body parts were dissected from the vitreous except for the strong
interconnections around the pars plana, which were initially left in
place to prevent damage to the vitreous cortex. Then, the lens capsule
was carefully dissected with most fibers of the zonula from the vitreous
base. The final step was the dissection of pars plana remnants consist-
ing largely of ciliary body fragments still adhering to the vitreous.31
Some vitreous base could have been removed during the latter proce-
dure. All VBs were weighed and stored at 20°C before freeze-drying.
In this study, VBs were divided in 24 pairs of left and right eyes, and
119 single eyes.
Freeze-drying
To reduce vitreous volume, VB samples were freeze-dried by a freeze-
dryer (Christ Alpha 1-4; Salm en Kipp, Breukelen, The Netherlands).
Before the drying process, the samples were put in liquid nitrogen. The
lyophilization was performed using a shelf temperature of –30°C, a
condenser temperature of –53°C and a pressure of 0.220 millibar
(mbar) for 18 hours. Then, the shelf temperature and pressure were
gradually increased to 20°C and 0.520 mbar, respectively, during 6
hours. Finally, the drying process was continued for another 20 hours
under these conditions. In a separate pilot analysis, we confirmed by
repetitive freeze-drying cycles that there was no loss of dry weight
sample (data not shown).
HPLC Analyses
Analyses of HP, LP, and amino acid content were performed by HPLC,
as described previously.32,33 The HPLC system (Separations Analytical
Instruments, Hendrik Ido Ambacht, The Netherlands) consisted of a
multisolvent delivery system (Model 480 pump; Gynkotek, Germering,
Germany), an autosampler (Triathlon; Spark Holland, Emmen, The
Netherlands), a fluorometer (Model 821-FP; Jasco Benelux, IJsselstein,
The Netherlands), and a degasser (Laboratory-Quatec Model Gastorr
Gt-103; Omnilab, Milan, Italy). Calibration of amino acids was per-
FIGURE 1. The synthesis of colla-
gen. (1) Collagen is synthesized as
pre-pro--chains. After translocation,
the signal peptides are removed and
the individual procollagen -chains
will associate through the C-pep-
tides. (2) Procollagens undergo mul-
tiple posttranslational modifications
such as the hydroxylation of specific
lysine (Lys) and proline (Pro) resi-
dues as well as the glycosylation of
hydroxylysyl residues. (3) The pro-
collagen is excreted and is converted
extracellularly into collagen by cleav-
ing the propeptides. (4) Subse-
quently, collagen molecules assem-
bly into ordered fibrils. (5) These are
finally stabilized by the formation of
intra- and/or intermolecular cross-
links. Reprinted with permission
from van der Slot-Verhoeven AJ. Te-
lopeptide lysyl hydroxylase: a novel
player in the field of fibrosis. Leiden:
University of Leiden; 2005. Thesis.
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formed with the amino acid standard for collagen hydrolysates (A-
9531; Sigma, St. Louis, MO).
Amino acids (hydroxyproline and proline) and cross-links were
determined after acid hydrolysis, as described previously.33 All freeze-
dried samples were hydrolyzed in 6 M HCl at 110°C for 20 to 24 hours.
After drying (Speed Vac SC 110; Savant, Farmingdale, NY), the speci-
mens were dissolved in 200 L water containing 10 M pyridoxine,
the internal standard for cross-link analysis and 2.4 mM homoarginine,
the internal standard for amino acid analysis (both from Sigma).
For cross-link analysis (Fig. 2), the samples were diluted in 0.5%
(v/v) heptafluorobutyric acid (HFBA; Fluka AG, Buchs, Switzerland) in
10% (v/v) acetonitrile (Rathburn, Walkerburn, Scotland). Separation
was performed on a 4.6 mm  150 mm reverse-phase column (Mi-
cropak ODS-80TM; Varian, Sunnyvale, CA). The column was equili-
brated with 0.15% (v/v) HFBA in 24% (v/v) methanol (solvent A).
Elution of pyridinolines and the internal standard pyridoxine was
achieved at ambient temperature at a flow-rate of 1.0 mL/min in two
isocratic steps: time 0 to 17 minutes solvent A; time 17 to 30 minutes
0.05% (v/v) HFBA in 40% methanol (solvent B). The column was
washed with 0.1% (v/v) HFBA in 75% (v/v) acetonitrile (solvent C) for
10 minutes and equilibrated for 10 minutes with solvent A, resulting in
a total analysis time of 50 minutes per sample. Fluorescence was
monitored with a programable fluorometer: 0 to 22 minutes 295/400
nm (pyridoxine and pyridinolines).
For amino acid analysis, aliquots of the hydrolyzed samples were
diluted in 0.1 M sodium borate buffer, pH 8.0, and derivatized at room
temperature for 5 minutes with 6 mM 9-fluorenylmethyl chloroformate
in acetone. Termination of the reaction and removal of excess reagent
and acetone was performed by extraction with 600 L pentane. After
two additional extractions, 400 L 25% acetonitrile in 0.1 M borate
buffer, pH 8.0, was added. A 50 L aliquot of the diluted sample was
injected into the HPLC system, after which separation was performed
on the above-mentioned reversed-phase column. Chromatography was
carried out at a column temperature of 40°C; fluorescence was moni-
tored at 254/630 nm. Solvent composition and the ternary gradient
have been described in detail, previously.32
Collagen cross-links are expressed as mol per mol collagen, assum-
ing 300 hydroxyproline residues per triple helical collagen molecule
(TH).34
Statistical Analysis
The HPLC results were analyzed by Student’s t-tests for differences
between two groups. Age-related phenomena were studied by linear
regression analysis and by curve estimation, a form of non-linear re-
gression using a quadratic model, by which a reversal or top of the
curve can be determined (an increase followed by a decrease for
example). The age at the reversal point (top of the curve) was used as
a cutoff point in the subsequent non-linear regression analyses. Right
and left eyes were compared by paired Student’s t tests. All analyses
were performed with data analysis software (SPSS, version 14.0 for
Windows; SPSS, Chicago, IL). When needed, the data were normalized
using log transformation. P  0.05 was considered to represent statis-
tically significant differences.
RESULTS
Right versus Left Eye
The 24 right and left VBs showed no significant differences
between right and left eyes in all test variables: (dry) weight,
hydroxyproline per proline, percentage of collagen, mg colla-
gen in total VB, HP/TH, LP/TH, (log) HP/LP, and (HP plus
LP)/TH (data not shown). Thus, VBs of one donor showed a
high correspondence between right and left eyes. Therefore,
FIGURE 2. An example of HPLC output. The first peak (*) represents HP; the second peak (**) represents LP.
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only one (randomly chosen) eye of each donor was used in
further analyses.
VB of Single Eyes
To detect age-related phenomena, single eyes of 119 donors
were analyzed with linear regression and curve estimation
followed by non-linear regression (Figs. 3A–F). Macroscopi-
cally, elder VBs appeared much smaller. By curve estimation
analysis, vitreous wet weight (mean  SD, 4.42  0.84 g; Fig.
3A) appeared to increase until 35 years (P  0.048) and to
decrease thereafter (P  0.001), while dry weight (40.1  9.8
mg) and VB collagen content (0.30  0.14 mg) only declined
significantly after 35 years and 50 years, respectively (both P
0.001; data not shown). By linear regression analysis, the hy-
droxyproline per proline ratio (0.17 0.069; Fig. 3B), which is
the ratio between collagenous and non-collagenous proteins,
diminished markedly with aging (P  0.001), whereas the
percentage of collagen (percentage of the dry weight; 0.75 
0.33%, Fig. 3C) remained constant over time (P  0.111). The
ratio between HP and LP (range 0.42 to 31.0, median 10.0) did
not change significantly (log transformed data: P  0.087).
Curve estimation analysis showed reversal points for HP/TH
(0.55 0.18; Fig. 3D), LP/TH (0.057 0.018; Fig. 3E), and (HP
plus LP)/TH (0.61  0.19; Fig. 3F) at approximately age 50
years. Both HP/TH and (HP plus LP)/TH accumulated until 50
years (both P  0.001) and decreased significantly thereafter
(P 0.020 and P 0.010, respectively). LP/TH increased until
50 years (P  0.003) and remained constant thereafter (P 
0.355). In our dataset, a few outliers were found and we did
not remove them, since they had no effect on our results (not
shown).
VBs showed no significant differences in the enzymatic
collagen cross-links in our sub analysis of diabetics (n  12)
versus non-diabetics (n 107); causes of death such as chronic
alcohol intoxication (n  5), vascular cause (n  73), pulmo-
nary cause (n 13), malignancy (n 19), and trauma (n 9);
FIGURE 3. The effect of age on the
vitreous body (VB). (A) VB weight
increased (P  0.048) until 35 years
and decreased thereafter (P 
0.001). (B) On aging, the hy-
droxyproline/proline (Hyp/Pro) ratio
declined (P  0.001). (C) The colla-
gen percentage remained constant
over time (P  0.111). (D) Until 50
years, hydroxylysylpyridinoline (HP)
per TH rose (P  0.001), whereas it
decreased thereafter (P 0.020). (E)
Lysylpyridinoline per TH (LP/TH) in-
creased until 50 years (P  0.003),
followed by a constant level (P 
0.355). (F) (HP plus LP)/TH showed
an increase (P  0.001) up to 50
years and diminished thereafter (P 
0.010).
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and time interval (1 to 12 days) between death and preparation
(data not shown). Finally, possible differences between sex (80
men and 39 women) were studied, since female sex is a risk
factor for the development of PVD,12,35,36 but no clear differ-
ences were found between men and women (data not shown).
DISCUSSION
This study shows an increase in the mature enzymatic collagen
cross-links HP and LP in the human vitreous body from child-
hood until 50 years, at which time decline (HP) or stabilization
(LP) occurs. For the VB cross-link composition, the influence of
LP appears to be limited, since HP is the most abundant
collagen cross-link and the HP/LP ratio does not change signif-
icantly on aging. Overall, the enzymatic cross-links (HP plus
LP) per TH increase until 50 years and decline thereafter.
The pyridinoline cross-links form the last enzymatic step in
collagen maturation. They provide physical and mechanical
strength to the collagen network and thus contribute to its
integrity.3 In this study, we cannot show a direct relationship
between age-related morphologic changes and enzymatic col-
lagen cross-linking. The direct relationship between enzymatic
cross-links and morphologic changes with aging has not been
studied in the VB.
In the VB, we find an increase in the enzymatic cross-links
per TH until 50 years. A possible explanation for the increase
could be the formation of enzymatic cross-links from the pro-
cessing of type II procollagen present in the VB.28 At this
moment, it is not known whether the amount of procollagens
in the vitreous changes with aging. Furthermore, the presence
of procollagens may indicate that collagen synthesis, and thus
cross-link formation, continuously take place with aging. This
latter hypothesis is supported by the finding of immature
cross-links in adult bovine vitreous.26 In older cartilage and
bone, immature cross-links decline in parallel with an increase
in mature enzymatic cross-links.37,38 In this study, we were
only able to measure the mature enzymatic cross-links. There-
fore, a direct relationship between increasing mature and de-
creasing immature cross-links could not be demonstrated. In
non-mineralized tissues (such as cartilage and vitreous) matu-
ration of immature collagen cross-links is probably a quick
process taking only one to four weeks.37,39–41 This is in con-
trast to mineralized ECMs (e.g., bone and dentine) in which
maturation of enzymatic cross-links is a slower process because
of the abundant presence of mineral.42
In addition to the increase in enzymatic cross-links per TH
until 50 years, we found a decline thereafter. This decrease
occurs at an age at which morphologic changes in the VB
become more prominent.14,17 A reasonable explanation could
be a breakdown or loss of collagen cross-links, which is sup-
ported by the decrease in collagen content after 50 years and
the morphologic presence of collagen fragments near liquefied
spaces.23 Results found in the VB are globally in agreement
with other human ECMs (bone, cartilage, meniscus, and inter-
vertebral disc) in which the maximum amount of enzymatic
cross-links is often reached in adolescence or midlife.10,38,43–46
At this moment, the only study concerning HP and LP in the
human VB, and thus our only reference for mature enzymatic
cross-links, is based on vitrectomy samples.47 However, this
study failed to detect age-related changes in HP and LP cross-
links. Possible explanations for this difference with our study
include a limited age range (38–77 years versus 4–80 years);
the use of vitrectomy samples (sampling error since the VB is
not a homogenous structure1,15,17,48); and the expression of
cross-links in nanograms per milliliter versus amounts per tri-
ple helix.
In the present study, the apparent increase in VB weight
and VB collagen weight until 35 and 50 years, respectively, and
the significant decrease thereafter was partly in agreement
with a previous study which showed a maximum total VB
weight around 40 years and a constant VB collagen content
from the third decade onward, preceded by a possible in-
crease.13 Because we found higher amounts of total vitreous
collagen weight (mean, 0.30 mg vs. 0.22 mg by estimation13),
it was not likely that we lost collagens during preparation,
although theoretically, a loss of macromolecules during prep-
aration in elder VBs is more likely than in younger VBs. The
increase followed by the decrease could be explained by a net
collagen synthesis followed by a net collagen breakdown (and
removal from the VB). In our opinion, it is impossible to
explain this phenomenon by the assumption that collagen
once formed never changes and only aggregates with aging.
Our hypothesis can be supported by morphologic studies that
showed an age-related loss of type IX collagen49 and found
evidence of collagen fragmentation near liquefied spaces.23
The hydroxyproline per proline ratio showed a significant
decrease with aging, implying a higher increase in the amount
of non-collagenous proteins than in the amount of collagens.
Non-collagenous proteins in the vitreous include glycoproteins
(such as opticin), proteoglycans (e.g., chondroitin sulfate), and
other structural proteins (e.g., fibrillin).1 Since glycoproteins
and proteoglycans are the most abundant non-collagenous pro-
teins of the VB,1 the change in hydroxyproline per proline ratio
could reflect an increase in these proteins. Alternatively, an
increase in total protein concentration with aging has been
described and found to be related to a progressive leakage of
serum proteins into the VB.50
Our results on enzymatic collagen cross-links can contribute
to the insight in the age-related processes of synchisis and
syneresis in the concept of collagen turnover. The accumula-
tion of collagen cross-links until 50 years is an indication of
(ongoing) collagen maturation, which in its turn can be the
result of collagen synthesis. At the age of 50 years, when
striking morphologic changes in the VB are evident,14,17 the
enzymatic collagen cross-links start to diminish. This decline
can be caused by collagen breakdown—but more importantly,
the decline itself can contribute to the instability of the colla-
gen network resulting in an increase in morphologic changes
in the elder VB.
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